Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Common Equity (2016 - 2025)

Cryoport (CYRX) has disclosed Common Equity for 13 consecutive years, with $502.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 25.07% to $502.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $502.6 million, a 25.07% increase, with the full-year FY2025 number at $502.6 million, up 25.07% from a year prior.
  • Common Equity was $502.6 million for Q4 2025 at Cryoport, down from $513.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $648.0 million in Q2 2021 to a low of $398.8 million in Q1 2025.
  • A 5-year average of $531.6 million and a median of $540.9 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: soared 439.19% in 2021, then fell 26.49% in 2024.
  • Cryoport's Common Equity stood at $641.8 million in 2021, then decreased by 13.4% to $555.8 million in 2022, then dropped by 12.02% to $489.0 million in 2023, then dropped by 17.82% to $401.9 million in 2024, then rose by 25.07% to $502.6 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Common Equity are $502.6 million (Q4 2025), $513.3 million (Q3 2025), and $519.1 million (Q2 2025).